Thank You to Our World Sleep 2022 Partners
All organizations are listed in alphabetical order.
Activinsights is a digital health company that specialises in the objective measurement of physical behaviours and lifestyle. Our technologies are used worldwide within the clinical trials, health management and research markets to provide accurate and continuous monitoring of lifestyle outside of the clinic environment. We develop novel health measures from data collected by our own professional wearables and other connected devices, within a scalable global and secure infrastructure.
Advanced Brain Monitoring, Inc.
Advanced Brain Monitoring specializes in the acquisition and analysis of physiological signal obtained during wake and sleep, and in the treatment of sleep-disordered breathing. Sleep Profiler monitors sleep quality in the home or ICU, provides unattended PSG, and/or delivers prodromal biomarkers for neurodegenerative disease. Night Shift provides electronic positional therapy from the neck or chest. Apnea Guard® is a trial oral appliance that provides equivalent efficacy as a custom appliance.
AmCad BioMed Corporation
AmCad BioMed Corporation (AmCad) is a pioneering ultrasound AI software company, creates a world’s first ultrasound based obstructive sleep apnea (OSA) detection in 10 minutes for awake patients, AmCAD®-UO. With laser-guided positioning and automated ultrasound scanning device, AmCAD®-UO can precisely scan upper airway and analyze the gap between normal breathing and Müller Maneuver. AmCAD®-UO system standardizes ultrasound transducer scanning to make the assessment more consistent and avoid high operator dependent variations.
AmLife commenced its sleep healthcare business in 2014. The company has pioneered the combination of a bedding equipment with Japan’s technology to expand the unlimited potential of the sleep healthcare market by providing a health solution for the daily use of a modern-day community. AmLife committed in promoting sleep health activities in the past few years, and AmLife holds a major World Sleep Day event each year.
Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective oral medication dosed once-daily at bedtime. Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. The company is developing a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.
Avadel is transforming medicines to transform lives by applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging its proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy.
The Bioprojet company was founded in 1982 under the impetus of Jeanne-Marie Lecomte and Jean-Charles Schwartz, doctors of pharmacy and sciences. From very different backgrounds, Jeanne-Marie Lecomte made her career in the pharmaceutical industry, whereas Jean-Charles Schwartz continued down the university pathway. They decided to bring together academic research and industrial pharmaceutical development, an uncommon practice at that time. With Bioprojet, they are following an objective based on novel fundamental research work in order to design and develop drugs destined to be forerunners in new therapeutic groups. To achieve this ambition, Bioprojet has partnered with Inserm, where Jean-Charles Schwartz leads a research unit, and with various Medicinal Chemistry university laboratories.
Today, Bioprojet is divided into two entities, bringing together hundred employees in charge of drug development and marketing:
– Bioprojet PHARMA, created in 1992, in charge of drug development and marketing.
– Bioprojet BIOTECH, created in 2001, in charge of R&D. There are four units: biochemistry / molecular biology, therapeutic chemistry, pharmacology and pharmacokinetics.
The Board of Registered Polysomnographic Technologists
The mission of The Board of Registered Polysomnographic Technologists (BRPT) is to build upon its history as the global leader in sleep technologist credentialing and certification; to provide high quality sleep technology products and services that inspire professional excellence, recognition, and lifelong learning; and to create long-term value for credential and certificate holders.
Bittium offers medical technology for monitoring biosignals in the areas of cardiology, neurophysiology, rehabilitation, and occupational health. Bittium develops cutting-edge technology for monitoring ECG and EEG. Bittium’s cardiac monitoring devices and applications include Holtering, cardiac telemetry, and cardiac rehabilitation. Bittium has EEG solutions for first aid and intensive care, TMS-EEG, and fMRI-EEG.
Cerebra is putting the “sleep back into sleep medicine”, transforming the future of sleep diagnosis and therapy through self-applied in-home polysomnography and our patented Odds Ratio Product (ORP). ORP moves beyond conventional scoring by micro analyzing the EEG signal to dig deeper into brain activity during sleep. This provides new insights in mental, physical, and emotional health. Cited in peer reviewed sleep research, ORP is the most accurate measure of sleep depth.
Datwyler is focusing on high-quality, system-critical elastomer components and has leading positions in attractive global markets such as healthcare, mobility, food & beverage and general industry. With its recognized core competencies, the company delivers added value to customers in the markets served. With more than 20 operating companies, sales in over 100 countries and some 7’000 employees Datwyler, headquartered in Switzerland, generates annual sales of more than CHF 1’000 million.
Diametos’ product Somnofox is the world’s first and only medical device for the analysis of the anatomical causes of snoring. Using artificial intelligence, the acoustic subtleties of the snoring sounds are analyzed, and the sleep specialist receives a detailed report. In addition, Diametos’ medical App Snorefox offers patients an easy way to assess the risk of Sleep Apnea at home. – Diametos makes snoring diagnostics as easy as snoring itself.
Dormiflex is a Venetian company specialised in the production of bed systems for the residential medical/health sector. The products are entirely made in Italy using only high-quality materials and the first company for Medical Devices. Dormiflex was established in 1964. Dormiflex is even capable of guaranteeing dreams, through technology, tradition and the continuous innovation of its patents with relentless research and development of the best sleeping solutions.
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We deﬁne our corporate mission as “giving ﬁrst thought to patients and their families and to increasing the beneﬁts health care provides,” which we call our human health care (hhc) philosophy.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care.
European Sleep Research Society
The ESRS is an international scientific non-profit organization that aims to: promote all aspects of sleep research and sleep medicine, improve the care for patients with sleep disorders and facilitate the dissemination of information regarding sleep research and sleep medicine. To do this, we publish the Journal of Sleep Research and Sleep Medicine Textbook, organize scientific events, including our biennial Sleep Europe Congress and offer several fellowships, grants and awards.
Fidia farmaceutici S.p.A.
Italian developer and leading manufacturer of innovative products mainly based on hyaluronic acid (+1,100 patents), in joint care, wound care, ophthalmology, uro-gynecology, aesthetic and regenerative medicine. Products are available in +100 countries, through wholly owned subsidiaries and partners. Fidia’s commitment is also dedicated to pathologies such as sleep disorders, mood regulation and peripheral neuropathies, realized through a valid offer of therapeutic options which are confirmed by a consolidated use over the years and by innovative proposals.
Fisher and Paykel Healthcare
Fisher & Paykel Healthcare. We are a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. Driven by a strong sense of purpose, we are working to improve patient care and outcomes through inspired and world leading healthcare solutions. The needs of our customers and their patients drive everything we do. We call this commitment Care by Design.
Happiest Baby is a mission-driven company dedicated to helping parents succeed at their most important job – raising healthy, happy children. We solve parenting challenges with smart, science-based solutions. SNOO Smart Sleeper-the safest baby bed ever made-is a responsive bassinet that boosts a baby’s sleep by combining gentle rocking with soothing white noise and safe swaddling. Created by Dr. Harvey Karp, SNOO helps babies by imitating the calming sensations of the womb.
The Hypersomnia Foundation engages, informs and champions our global community to improve the lives of people with idiopathic hypersomnia and related sleep disorders.
Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
Jazz Pharmaceuticals is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology.
INT-JPC-2100037 | October 2021
Löwenstein Medical is dedicated to the development, prouction, sales and marketing of medical devices in three main business divisions – hospital, homecare and diagnostics. Workstations for anesthesia, neonatology, pediatrics and intensive care ventilation describe the focus areas in the hospital segment. Moreover are diagnostic and therapeutic solutions for sleep medicine and homecare ventilation among the core competencies of the firm.
Moona’s mission is to improve sleep for millions using breakthrough technology and AI. Medical research shows that temperature is a key factor in sleep quality. Fluctuations in body temperature regulate the body’s circadian rhythm, and our sleep. Using this link between body temperature and sleep, Moona’s first product tracks and understands sleep then regulates the head and neck temperature through a thermoregulated pillow pad, a pod, and a companion app.
Founded in 1986, Narcolepsy Network is the national U.S. membership-governed organization dedicated to improving the lives of people with narcolepsy. Our goals include increasing public awareness, advocating for all people with narcolepsy, educating people with narcolepsy and the public at large and supporting research.
Neurim Pharmaceuticals Ltd. (www.neurim.com) is a pharma company focusing on discovering and developing innovative drugs for CNS diseases. In response to the unmet medical need of children with ASD suffering from insomnia, Neurim developed Slenyto® – the first and only age-appropriate formulation, indicated for the treatment of insomnia in children and adolescents aged 2-18 with ASD or Smith-Magenis syndrome (SMS).
NLS Pharmaceutics is a Swiss clinical-stage biopharmaceutical company led by an experienced management team with a track record of developing and repurposing product candidates to treat rare and complex CNS disorders. The Company’s lead product candidate, a proprietary extended-release formulation of mazindol (mazindol ER), is being evaluated in a phase 2 study in the US in adult subjects with narcolepsy. Mazindol is a triple monoamine reuptake inhibitor and partial orexin-2 receptor agonist.
Nox Medical provides sleep specialists with patient-friendly sleep diagnostic devices and robust, reliable data collection. With easy-to-use medical device technology, Nox Medical eliminates common diagnostic pain points by prioritizing patient comfort and reliability of results, allowing providers to better assess, diagnose and treat the entire range of sleep health issues.
Nukute introduces a novel method for home sleep apnea testing and the remote diagnosing of sleep apnea. Careful thought has been put into the usability of the system and patient comfort during sleep. Enabling all new possibilities for physicians and clinics conducting sleep studies, Nukute’s tracheal auscultation technology e.g. facilitates two consecutive nights of home sleep apnea testing, and is easily used alongside any type of breathing aid device. The system sends the overnight data directly to the cloud to be processed by AI, after which the physician has immediate access to the results – from home or anywhere else. Please find out more from the poster “Novel wearable technology to screen for sleep apnea”, accompanied by its oral presentation at World Sleep 2022 and visit our booth 647 at the Exhibit Hall!
OrthoApnea is a Spanish company that designs, manufactures and supplies since 1992 Mandibular Advancement Devices (MADs) for treating Obstructive Sleep Apnea Syndrome. OrthoApnea has launched NOA, the first MAD designed based on the anatomy of the patient considering their arthrokinematic parameters. NOA is a 100% unique device for each patient and therefore the most effective, most comfortable and safest device. Our core values are innovation, quality, efficiency and customer service.
Panthera Dental is committed to design and manufacture state-of-the-art products using proprietary CAD/CAM processes, smart manufacturing and superior quality materials, to provide the highest quality outcomes through their highly skilled and dedicated employees, to deliver peerless solutions to dental, medical and sleep professionals who strive to improve patients’ quality of life worldwide.
Philips is a leading health technology company focused on improving people’s lives across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and insights, Philips addresses the Quadruple Aim: improved patient experience, better health outcomes, improved staff experience, and lower cost of care. Philips is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
ProSomnus® Sleep Technologies
ProSomnus is the leader in precision, patient preferred oral appliance devices for OSA. 96% of patients prefer ProSomnus devices, citing comfort and resolution of complaints (IRB, 2021). Biomechanically engineered, studies associate ProSomnus devices with excellent efficacy, adherence, and mitigation of side effects.
At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases.
Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
Sleep Number delivers life-changing innovations informed by science. Aligned with our purpose of improving the health and wellbeing of society, we’re committed to advancing sleep health, linking smart sleep to individualized wellness via innovations informed by data and scientific expertise. Our proprietary sleep ecosystem and real-world sleepers generate billions of accurate, longitudinal data points every night, conducting one of the largest real-world sleep studies each night.
Sleepiz AG (Ltd.) is a Zürich based startup with a mission to provide patient-centric disease management through seamless integration of contactless monitoring into people’s homes. Sleepiz leverages the power of sleep insights with a non-contact device that is simply placed next to the bed. The Sleepiz One Connect measures breathing rate and patterns, pulse and SpO2 with medical grade accuracy. Sleepiz is touching lives without touching.
SomnoMed® is an Australian Stock Exchange listed medical device company operating in 28 countries, with headquarets in Sydney, Australia and offices in Europe and the United States. SomnoMed® focuses on developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA) and more than 625,000 patients around the world have been successfully treated with our oral appliances.
SOMNOmedics designs, manufactures, markets, distributes and services products dedicated to sleep diagnostics. Our products are utilized for a variety of sleep related tests and comply with the AASM standards. SOMNOmedics devices are small, lightweight and worn by the patient. We are compatible with in lab diagnostics as well as home sleep testing. SOMNOmedics wireless solution allows patients video, audio and data to be observed from any environment.
Takeda Neuroscience is driven by the unmet needs of patients with rare neurological diseases. Our mission is to bring innovative and potentially disease-modifying medicines to these patients. To deliver on this mission, our approach leverages advances in molecularly and genetically defined targets, biomarkers, and targeted modalities.
Tufts University School of Dental Medicine, Office of Continuing Education
Tufts University School of Dental Medicine, Division of Continuing Education is dedicated to providing patient-centered and clinical-based education for the lifelong learning needs of dental professionals. We strive to develop educational programs that address different patient populations, dental specialties, advancing technologies, and varied practice settings. We create and coordinate programs that incorporate all type of educational methodologies, quality training, and the highest standards of oral health care by utilizing a comprehensive and multidisciplinary approach.
Vivisol is one of the leading Home Care Service Providers in Europe. Our patient management model includes all components of care: healthcare services, highly complex technological therapies and digital tools that allow to make the home environment proper to give continuity to the care path. Managing thousands of patients suffering from Sleep disorders, we are committed to offer innovative services by investing in diagnostic, therapeutic and follow-up personalized solutions.
Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA.
For more information, visit www.vivos.com
Our prescription WatchPAT® family of products, which utilize the PAT® signal, is designed to enable patients suspected to have sleep-related breathing disorders to easily conduct sleep apnea test in the comfort of their homes in accordance with physicians instructions, as authorized by qualified medical personnel while delivering the treating physician with comprehensive, accurate and reliable results to aid in diagnosis of sleep apnea.